Gordon W. Moran

3.9k total citations
96 papers, 1.5k citations indexed

About

Gordon W. Moran is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Gordon W. Moran has authored 96 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Genetics, 43 papers in Epidemiology and 35 papers in Surgery. Recurrent topics in Gordon W. Moran's work include Inflammatory Bowel Disease (62 papers), Microscopic Colitis (37 papers) and Helicobacter pylori-related gastroenterology studies (14 papers). Gordon W. Moran is often cited by papers focused on Inflammatory Bowel Disease (62 papers), Microscopic Colitis (37 papers) and Helicobacter pylori-related gastroenterology studies (14 papers). Gordon W. Moran collaborates with scholars based in United Kingdom, Canada and United States. Gordon W. Moran's co-authors include Subrata Ghosh, John McLaughlin, Gilaad G. Kaplan, Remo Panaccione, Cynthia H. Seow, Marietta Iacucci, Shellie Radford, James Hubbard, Catherine O’Neill and Ebby George Simon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

Gordon W. Moran

83 papers receiving 1.5k citations

Peers

Countries citing papers authored by Gordon W. Moran

Since Specialization

Citations

This map shows the geographic impact of Gordon W. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon W. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon W. Moran more than expected).

Fields of papers citing papers by Gordon W. Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon W. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon W. Moran. The network helps show where Gordon W. Moran may publish in the future.

Co-authorship network of co-authors of Gordon W. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon W. Moran. A scholar is included among the top collaborators of Gordon W. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon W. Moran. Gordon W. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P0371 Building a Robust Artificial Intelligence Solution for Use in Ulcerative Colitis Clinical Trials 2025 ·Journal of Crohn s and Colitis ·Michelle L. Byrne, James Requa, Julián Panés, Brian Bressler, Remo Panaccione, (unknown), (unknown), Nasim Parsa, Rupa Banerjee, Rakesh Kalapala, D. Nageshwar Reddy, (unknown), (unknown), Gordon W. Moran, (unknown), Vincent Cheung, (unknown), Christopher Ma, Simon Travis, Vipul Jairath	1
2	Immunomodulators and Advanced Therapies for Induction of Remission in Crohn’s Disease: A Systematic Review and Network Meta-Analysis 2025 ·Inflammatory Bowel Diseases ·Vassiliki Sinopoulou, Morris Gordon, (unknown), Deijanira Albuquerque, Aderonke Ajiboye, Sudheer K. Vuyyuru, Shellie Radford, Gordon W. Moran	0
3	Prepublication abstract-only reports compared with full-text manuscripts for randomised controlled trials in inflammatory bowel disease: a systematic review 2024 ·BMJ Open Gastroenterology ·Vassiliki Sinopoulou, Morris Gordon, Gordon W. Moran, Abdullah Egiz, (unknown), (unknown), (unknown)	2
4	DOP02 Developing explicit thresholds for outcomes to inform (GRADE) Evidence to Decision frameworks for Inflammatory Bowel Disease guidelines 2024 ·Journal of Crohn s and Colitis ·(unknown), Vassiliki Sinopoulou, Sudheer K. Vuyyuru, Gordon W. Moran, Morris Gordon	2
5	Delphi consensus survey: the opinions of patients living with refractory ulcerative proctitis and the health care professionals who care for them 2023 ·BMJ Open Gastroenterology ·(unknown), Shellie Radford, Gordon W. Moran	1
6	BSG 2024 IBD guidelines protocol (standard operating procedures) 2023 ·BMJ Open Gastroenterology ·Morris Gordon, (unknown), Vassiliki Sinopoulou, Ajay Verma, Klaartje Kok, Kamal Patel, Jimmy K. Limdi, Naila Arebi, Philip J Smith, Shahida Din, Said Din, Matthew Shale, (unknown), Polychronis Pavlidis, Rachel Cooney, Dennis McGonagle, Newton A C S Wong, Gordon W. Moran	10
7	Systematic review of sarcopenia in inflammatory bowel disease 2023 ·Clinical Nutrition ·(unknown), (unknown), Rebecca Stevenson, (unknown), (unknown), Philip J. Atherton, Matthew S. Brook, Gordon W. Moran	29
8	Systematic review: Sarcopenia in paediatric inflammatory bowel disease 2023 ·Clinical Nutrition ESPEN ·(unknown), Kostas Tsintzas, (unknown), Shellie Radford, Gordon W. Moran	3
9	Acute effects of prior dietary fat ingestion on postprandial metabolic responses to protein and carbohydrate co-ingestion in overweight and obese men: A randomised crossover trial 2022 ·Clinical Nutrition ·(unknown), (unknown), Joanne Mallinson, (unknown), Robert Jones, (unknown), Warwick B. Dunn, Gordon W. Moran, Francis B. Stephens, Kostas Tsintzas	3
10	OFR-9 An RCT of autologous stem-cell transplantation in treatment refractory Crohn’s disease (low-intensity therapy evaluation): ASTIClite 2021 ·James Lindsay, Shahida Din, C J Hawkey, Daniel Hind, Peter M. Irving, Alan Lobo, (unknown), Gordon W. Moran, Miles Parkes, Jack Satsangi, (unknown), (unknown), Simon Travis, John A. Snowden	1
11	Evolution of treatment targets in Crohn’s disease 2019 ·Best Practice & Research Clinical Gastroenterology ·Jonathan White, Vipul Jairath, Gordon W. Moran	4
12	Gastrointestinal peptides and small-bowel hypomotility are possible causes for fasting and postprandial symptoms in active Crohn’s disease 2019 ·American Journal of Clinical Nutrition ·(unknown), Caroline L. Hoad, Alex Menys, (unknown), Shellie Radford, Stuart A. Taylor, (unknown), Melanie Lingaya, (unknown), Gulzar Singh, Robert E. Spiller, Penny Gowland, Luca Marciani, Gordon W. Moran	15
13	Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study 2017 ·The American Journal of Gastroenterology ·Christopher Ma, Gordon W. Moran, Eric I. Benchimol, Laura E. Targownik, Steven J. Heitman, James Hubbard, Cynthia H. Seow, Kerri L. Novak, Subrata Ghosh, Remo Panaccione, Gilaad G. Kaplan	132
14	Ustekinumab: a novel therapeutic option in Crohn’s disease 2016 ·Expert Opinion on Biological Therapy ·Ebby George Simon, (unknown), Subrata Ghosh, Gordon W. Moran	8
15	Novel concepts in inflammatory bowel disease 2014 ·British Medical Bulletin ·Gordon W. Moran, (unknown), Gilaad G. Kaplan, Remo Panaccione, Subrata Ghosh	3
16	Acute dysphagia after a normal endoscopy: think outside the box 2013 ·Clinical Medicine ·(unknown), Ray Mathew, Gordon W. Moran	1
17	Dipeptidyl peptidase-4 expression is reduced in Crohn's disease 2012 ·Regulatory Peptides ·Gordon W. Moran, Catherine O’Neill, (unknown), John McLaughlin	40
18	Enteroendocrine cells in terminal ileal Crohn's disease 2012 ·Journal of Crohn s and Colitis ·Gordon W. Moran, Joanne L. Pennock, John McLaughlin	46
19	GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier 2012 ·Regulatory Peptides ·Gordon W. Moran, Catherine O’Neill, John McLaughlin	43
20	Enteroendocrine cells and appetite dysregulation in Crohn's disease 2011 ·Gut ·Gordon W. Moran, John McLaughlin	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact